The effect of thymectomy and of the dose of 3-methylcholanthrene on the induction and antigenic properties of sarcomas in C56Bl mice. by Johnson, S.
93
THE EFFECT OF THYMECTOMY AND OF THE DOSE OF 3-METHYL-
CHOLANTHRENE ON THE INDUCTION AND ANTIGENIC
PROPERTIES OF SARCOMAS IN C57B1 MICE
SUSAN JOHNSON
From the Cancer Research Laboratories, Department ofPathology,
The Medical School, Birmingham, 15
Received for publication November 10, 1967
MANY tumours induced by chemical carcinogens have been shown to be anti-
genic when transplanted into syngeneic hosts (Foley, 1953; Baldwin, 1955; Prehn
and Main, 1957; Revesz, 1960) and even into the autochthonous host (Klein et al.,
1960). The immunological response elicited by these tumour-specific antigens is
similar in some respects to the homograft reaction in that the immunity is trans-
ferable from one animal to another by means of sensitized cells (Billingham et al.,
1954; Mitchison, 1954; Gowans, 1962; Billingham et al., 1962; Amos, 1962), but
not consistently transferable by means of serum (Klein et al., 1960; Brent and
Medawar, 1962; Old et al., 1962).
The question arises as to why such antigenically foreign cells are not destroyed
by an immunological response from the host before they become established as a
tumour. It has been shown that 3-methylcholanthrene (MC) can have a depres-
sive effect on the immunological response of the host, including the homograft
reaction (Rubin, 1960; Prehn, 1963), and it has been suggested that interference
with the immune mechanism may be a necessary part of chemical carcinogenesis.
This hypothesis is further supported by the fact that animals whose immunological
defences have been impaired by thymectomy soon after birth, are more susceptible
to the induction of tumours by carcinogenic agents (Vandeputte et al., 1963;
Miller et al., 1963; Malmgren et al., 1964; Kirschstein et al., 1964; Miller etal., 1964;
Grant and Miller, 1965; Nishizuka et al., 1965).
The degree of antigenicity of tumours induced by the same carcinogen varies
from high to low or absent, when measured by the ease with which the immunity
induced in syngeneic mice can be broken down by challenge with viable tumour
cells (Prehn andMain, 1957, Old et al., 1962). Old and his collaboratorspostulated
that the latent period of tumour induction by chemical carcinogens is a selection
period in which the most antigenic neoplastic cells are eliminated, and tumours
only appear when the growth potential is capable ofoverriding the immunological
response elicited by the antigenic nature ofthetumour cells. They predicted that,
if this hypothesis were true, the earliest tumours to appear would be highly
antigenic when compared with the tumours which appear later and which have
been subjected to a longer period of selection. In a study of a group of eleven
tumours induced by MC in BALB/c mice the first four tumours to appear were
highly antigenic and the later ones were either less antigenic, or possessed no
demonstrable antigenicity. These few results do no more than suggest a sequen-
tial process of modification during carcinogenesis in which there is a progression
towards less and less antigenicity, but if the hypothesis on which the experimentSUSAN JOHNSON
was based is correct, one would expect that chemical carcinogenesis in animals
with impaired immunological reactivity would lead to highly antigenic tumours.
Also, if depression of the host's immunological defences is an important aspect of
chemical carcinogenesis, one would expect tumours induced by larger doses of
carcinogen, not only to appear sooner, but also to be more antigenic than tumours
induced by smaller doses of the same carcinogen, in animals of the same sex and
strain.
The purpose of the present experiment was to investigate the effects of thy-
mectomy, and ofan increased dose ofcarcinogen, on the induction and antigenicity
of tumours induced in C57B1 mice, and also to compare the antigenicities ofearly
and late appearing tumours.
MATERIALS AND METHODS
Mice
Male and female mice of the C57BI/Bcr strain were used in this study. They
belonged to the 31st to the 36th generations of brother-sister matings in the
Birmingham Laboratories. The mice were housed in metal boxes measuring
20 x 28 x 11 cm. with five mice to a box. "Rat and Mouse Breeding Diet"
(Heygate, Bugbrooke Mills, Northampton) was given in cube form with water
ad libitum.
Thymectomy
Micewerethymectomized three days afterbirth. Mortality dueto cannibalism
was reduced by trimming the lower incisors of the mothers under light ether
anaesthesia.
Carcinogen treatment
At six weeks of age the mice were injected subcutaneously in the right flank
with 0 05 ml. of a solution ofMC in olive oil. The dose given was either 025 mg.
or 1 00 mg. ofMC.
Appearance of the tumours
Mice were palpated every week after the injection of carcinogen and the time
ofappearance andsubsequent size ofthe tumour attheinjection site were recorded.
Tumour size was assessed by palpation and comparison with a graded series of
ball-bearings of known diameter which had been sewn between two pieces of
chamois leather; a technique devised by J. W. Orr in these laboratories. The
diameter of the ball-bearings ranged from 2 inch to 12 inch, increasing in units
of k inch.
Experimental design
Three groups of mice were set up as follows:
Group 1 20 male and 20 female thymectomized mice injected with 0-25 mg. of
MC.
Group 2 15 male and 15 female intact mice injected with 1.00 mg. ofMC.
Group 3 15 male and 15 female normal intact mice injected with 0-25 mg. of MC.
A larger number of mice was included in group 1 to guard against loss from
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extraneous causes, such as infections, to which thymectomized mice seem to be
particularly susceptible. All mice were killed when their tumours reached a
diameter of 12 inch, or earlier if their condition made it necessary. All the
thymectomized mice were examined macroscopically at autopsy for thymus
remnants. It was not possible to examine the antigenicity of every tumour
The first and last tumours, and a sample ofthose appearing atintervals inbetween,
were tested in each experimental group.
Assessment of tumour antigenicity
Antigenicity is defined here as the percentage inhibition of tumour growth
rate in mice which have been previously immunized with the tumour, as compared
with the growth rate in untreated controls. The design ofthe antigenicity test is
shown in Fig. 1. Immunization and challenge was by means of viable cell
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FIG. 1.-Design of the antigenecity test
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suspensions prepared by trypsinization of the tumour. The viability of the cells
was assessed by the exclusion of eosin in a haemocytometer. About ten syn-
geneic mice of the same sex as the primary host were inoculated subcutaneously
in the left flank with 5 x 105 viable tumour cells. The mice were inspected
weekly and the time of appearance and subsequent growth rate of the tumours
were recorded. When they reached a diameter of inch the tumours were
surgically removed from all but one mouse whose tumour wasusedfortheprepara-
tion of the challenging cell suspension. Between one and two weeks after the
removal of the last tumour, the immunized mice, along with five unimmunized
mice of the same age, sex and strain, were inoculated in the right flank with
103 viable cells. The challenging dose was injected into the opposite flank to the
immunizing dose so that any regrowth of the challenging dose was not confused
with the occasional regrowth of the immunizing tumour. The mice were in-
spected weekly and the time of appearance and subsequent growth rate of each
tumour were recorded. The degree of antigenicity was then expressed by the
ratio:
Mean tumour growth Mean tumour growth
rate in control mice - rate in immunized mice
Mean tumour growth
rate in control mice
RESULTS
Several mice died from a lung infection before the time when tumoursbeganto
appear, and these mice were not included in the analysis of the results. No
thymus remnants were found in any of the thymectomized mice.
Tumour incidence
The final incidence of tumours in the three groups after 25 weeks is shown in
Tables I and IT. These figures remained unchanged after a further six months.
Thymectomy did not significantly increase the incidence of tumours induced by
0-25 mg. of MC (P > 0.05, Chi-square test). On the other hand, the four-fold
increase in the dose of MC in group 2 resulted in a significantly higher incidence
of tumours in intact mice (P < 0.05).
Latent period
During the first few weeks after the injection of the carcinogen there was
often, but not always, a diffuse swelling ofthe area around the injection site, which
may have been an inflammatory reaction to the injection. Frequently the
adjacent lymph node was enlarged. Sometimes this swelling subsided and a
period of several weeks followed before a tumour appeared. In some cases the
swelling remained until eventually a tumour emerged from the centre of the area
and progressively grew to a diameter of 12 inch. In others the swelling lingered
for a few weeks and then partially subsided before a tumour appeared. Graphs
representing the changes which occurred at the injection site of each mouse are
shown in Fig. 2, 3 and 4. Since the swelling at the injection site did not always
occur, andwhen itdid, palpationofthe very early stages ofthe growth ofa tumour
was impossible, it was necessary to have a standard criterion for judging the
latent period of each tumour. The latent period was therefore determined from
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the growth curve as the number of weeks after the injection of MC when the
diameter of the swelling at the injection site was last 1-A inch.
The percentage ofmice with tumours at weekly intervals following the admini-
stration of MC is shown in Tables I and II. At no time was there a significant
difference between groups 1 (thymectomized, 0-25 mg. of MC) and 2 (intact,
1 00 mg. of MC) (P > 0 05, Chi-square test). Comparison of these two groups
independently with group 3 (intact, 025 mg. ofMC) shows that, in both cases the
difference in the percentage of mice with tumours rose to a peak at sixteen weeks
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FIG. 4.-Growth curves of the tumours in Group 3 (intact mice, 0'25 mg. ofMC).
and then declined. At sixteen weeks there were significantly more tumours in
group 1 than in group 3 (P < 0.05). At all other times the difference was not
significant (P > 0.05). From the fourteenth week onwards there were signifi-
cantly more tumours in group 2 than in group 3 (P < 0.05). The difference
became less with time after the sixteenth week, but the final incidence oftumours
was higher in group 2.
Growth rate
The time taken to grow from a diameter of -146 inch to 12 inch was taken as an
index of the growth rate of each tumour. This averaged 33 days (standard
deviation = 8 days) in group 1, 31 days (SD = 10) in group 2, and 37 days
(SD = 11) in group 3. There was no significant difference between these figures
TABLE I.-Effect ofThymectomy on the Incidence ofSarcomata Induced
by MC in C57B1 mice
Number of mice with sarcomata at weekly intervals following injection of MC
Percentage in parenthesis.
Weeks . . 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Group 1-
Thymectomized .3 4 7 9 9 13 18 19 20 20 20 22 23 23 23 23 23 23
0,25 mg. of MC . (11) (15) (26) (33) (33) (48) (66) (70) (74) (74) (74) (81) (85) (85) (85) (85) (85) (85)
(27 mice)
Group 3-
Intact . . 1 1 3 4 6 6 8 9 9 10 12 13 13 13 13 14 15 16
0-25 mg. MC * (5) (5) (15) (20) (30) (30) (40) (45) (45) (50) (60) (65) (65) (65) (65) (70) (75) (80)
(20 mice)
Difference. .6 10 11 13 3 8 26 25 29 24 14 16 20 20 20 15 10 5
between %
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TABLE II.-Effect of the Dosage ofCarcinogen on the Incidence of
Sarcomata Induaed by MC57Bl Mice
Number of mice with sarcomata at weekly intervals following injection of MC
Percentage in parenthesis.
Weeks . . 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Group 2-
Intact . . 2 4 5 9 11 14 19 22 23 23 24 26 26 26 26 26 27 27
1P00 mg. MC . (7) (15) (19) (33) (41) (52) (70) (81) (85) (85) (89) (96) (96) (96) (96) (96) (100) (100)
(27 mice)
Group 3-
Intact . . 1 1 3 4 6 6 8 9 9 10 12 13 13 13 13 14 15 16
0-25 mg. MC . (5) (5) (15) (20) (30) (30) (40) (45) (45) (50) (60) (65) (65) (65) (65) (70) (75) (80)
(20 mice)
Difference . 2 10 4 13 11 22 30 36 40 35 29 31 31 31 31 26 25 20
between %
when analysed using a Kruskal-Wallace analysis of variance (H = 1 6, df = 2,
P > 0.05) (Siegel, 1956). Thus, although tumours appeared earlier in groups 1
and 2 than in group 3, there was no difference between the three groups in the
rate of growth of the tumours once they had become established. However, it is
apparent from the growth curves in Fig. 2, 3 and 4, that the incidence ofthe swell-
ing at the site ofthe injection ofthe carcinogen before the appearance ofa palpable
tumour, was different in the three groups of mice. To determine how significant
this difference was the shapes of growth curves were analysed statistically in the
following way. The growth curves of all the tumours from the three treatment
groups were ranked on a shape continuum shown in Fig. 5. This ranking was
carried out by two judges, the positions of the growth curves on the continuum
being decided by discussion. A Kruskal-Wallace one-way analysis of variance
(Siegel, 1956) on the three sets of ranking values indicated that the three groups
differedintheshapes oftheir tumourgrowth curves (H = 17 8, df = 2,P < 0 001).
In order to examine exactly how the treatment groups differed, Mann-Whitney
U tests (Seigel, 1956) were performed on all three groups considered in pairs.
Curves with high ranking values (i.e. straight growth curves) occurred significantly
more frequently in groups 1 and 2 than in group 3 (P < 0.001). Groups 1 and 2
did not differ from each other in this respect. That is, the appearance of the
swelling at the injection site before the appearance of a tumour was less frequent
in mice which were thymectomized, or given a large dose of carcinogen, than in
intact mice given a lower dose.
Antigenicities of the tumours
The antigenicities and latent periods of the tumours are compared graphically
in Fig. 6. The Pearson product-moment correlation coefficient, r, was used to
index the relationship between these two variables. In all the groups latent
period and antigenicity were highly negatively correlated; for group 1, r = - 0-89
for group 2, r = - 0-84, and for group 3, r = - 0-90. All correlations were
significant (P < 0.001). That is, tumours with the shortest latent periods had
highly antigenic properties.
The antigenicities of the tumours in the three groups were analysed by means
ofone-tailed Mann-Whitney U tests (Siegel, 1956). The three groups ofmice were
considered in pairs. The results indicated that the antigenicities of the tumours
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in group 1 did not differ significantly from the antigenicities of the tumours in
group 2 (P > 0.05), but the tumours in groups 1 and 2 were significantly more
antigenic than those in group 3 (P < 0-05). That is, thymectomy of the host, or
increasing the dose of MC administered, led to the induction of more highly
antigenic tumours.
Only in the thymectomized group of mice was a sufficient number of tumours
tested for the correlation between tumour antigenicity and sex of the host to be
investigated. A Mann-Whitney U test was performed on the data in this group.
Tumours from male mice were found to be more antigenic than tumours from
female mice (U = 25-0, P < 0.05).
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FIG. 5.-Shape continuum for ranking of the growth curves.
DISCUSSION
In the present work thymectomy has been shown to shorten the latent period
of tumour induction by MC in C57B1 mice. However, the incidence and growth
rate of the tumours, once they had become established, was unaffected by thy-
mectomy. Thus the enhancing effect of thymectomy on carcinogenesis, although
significant, was not very great. It would seem that, although tumours are
initially able to establish themselves more easily in immunologically impaired
animals, conditions for their growth may not be optimal. There may be other
non-immunological functions of the thymus which have not yet been discovered.
These results are similar to those obtained by Grant and Miller (1965) who also
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found that sarcomas induced by MCinAC57Bl mice, which had been thymecto-
mized at three days of age, had a shorter latent period than similar tumours
induced in sham-thymectomized controls.
There has been one report of findings which are contrary to these. Balner
and Dersjant (1966) found that thymectomy of C57B1 mice did not affect the
latent period of induction of sarcomas by MC. However, these mice were thy-
mectomized within 24 hours ofbirth, whereas in the present study and in the work
ofGrant and Miller, thymectomy was performed at three days ofage. The earlier
thymectomy in the experiment of Balner and Dersjant may have had a more
GROUP 1.THYMECTOMIZED:0 25mg. MC
- e..
.-
*00
IF
GROUP2.INTACT:1 00mg. MC
GROUP3. INTACT:0-25mg. MC
* * S
GRU3 ,NTACT:.25mg. M
8 12 16 20 24 28 32 36
TIME OF APPEARANCE OF SARCOMA
(WEEKS AFTER MC INJECTION)
FiG. 6.-Variation of the antigenicity with the latent period of each
sarcoma in the three groups of mice treated with MC.
marked effect on the non-immunological factors concerned with tumour growth.
Another difference in the conditions of their experiment was that both the
thymectomized and the control mice were grafted with a piece of allogeneic skin
at eight weeks of age, before the administration ofthe carcinogen. It may be that
the graft constituted a sufficient non-specific stimulation of the host's defective
immunological defences to counteract the effects of thymectomy.
Evidence has been cited in the introduction supporting the suggestion that
interference with the immune response may be an important aspect of carcino-
genesis. There are several possible roles for a chemical carcinogen during the
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course of tumour production. The carcinogen may do no more than depress the
host's immunological defences, preventing the elimination of mutant antigenic
clones, someofwhich maybe neoplastic and which, according to Burnet's postula-
tions (Burnet, 1964), arise spontaneously throughout the life of the animal.
This would be an extremely passiverole for the carcinogen. In the present work a
comparison was made between the effects ofthymectomy soon after birth and the
effects of increasing the dose of carcinogen on the induction of sarcomas by MC.
MC is known to depress the host's immunological defences and with the additional
depressing effect of thymectomy, and probably of an increased dose of MC, one
would expect enhanced tumour induction. Both treatments caused shortening
ofthe latent period, but only in the group ofmice given the high dose ofcarcinogen
was the final incidence of tumours increased. This suggests that, unlike thymec-
tomy, the action of MC is not limited to the passive role of simply depressing the
host's immunological defences, but may be actively concerned in the production of
neoplastic cells. It may increase the frequency of somatic mutation, thereby
increasing the number of potentially malignant cells which normally arise spon-
taneously (Burnet, 1964), or the carcinogen may act more specifically on a self-
replicating (nucleic acid) system, directly converting normal cells to neoplastic
ones. On the other hand the higher incidence of tumours in the group of mice
given a high dose of carcinogen may simply be due to a more severe depression of
the host's defences than occurs as a result ofthymectomy. It is of course possible
that the carcinogen exerts both these effects on the host's tissues simultaneously.
The production ofspecific antigens may be an integral part ofthe change from
the normal to the neoplastic state, or it may be a separate unrelated process.
The progression towards less and less antigenic tumours as the latent period
increases, demonstrated in the present work, suggests that specific antigens are
not essential for the neoplastic behaviour of the cells. These results which are
in agreement with the preliminary findings of Old et al. (1962), support the hypo-
thesis that the latent period is a selection period in which the earliest tumours to
appear are so highly antigenic that they are destroyed by the host, and that a
tumour appears when a neoplastic cell arises which is less antigenic and has a
growth potential capable of overriding any immunological control.
Further support for this selection hypothesis is provided in these studies by
the demonstration that chemical carcinogenesis under conditions of reduced
immune activity (i.e. thymectomy) gave rise to tumours which were highly
antigenic. The fact that a four-fold increase in the dose of MC administered to
intact mice led to the induction of tumours which were as highly antigenic as
those induced by the original low dose in the thymectomized group, suggests
that the increase in the dose of MC had a similar immuno-depressive effect to
thymectomy. The results of the analysis of the shapes of the growth curves of
the individual sarcomas may also be relevant here. The swellings at some
injection sites of MC may have been due to a host reaction against early arising,
highly antigenic tumour cells. Although it is not possible to conclude from these
studies what the nature of these swellings was, it is interesting to note that such
swellings were significantly less frequent in mice which were thymectomized or
given a high dose of carcinogen, and that the latter two groups of mice did not
differ from each other in this respect. The appearance of these swellings at the
site of the carcinogen injection thus correlated with the immunological capacity
of the host. If these swellings did represent a reaction to early arising, highly
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antigenic tumour cells, their absence from many ofthe mice treated with the high
dose of carcinogen suggests that the MC exerts a depressive effect on the host's
immunological capacities soon after it is injected. This is further supported by
the work of Stjernsward (1965), in which the effects of MC on the number of
antibody-forming cells in the spleen after immunization with sheep erythrocytes
was studied. As early as two days after an intramuscular injection of MC the
number ofantibody-forming cells was reduced by more than 50 per cent. Depres-
sion of an early immunological response to antigenic neoplastic cells may explain
how such cells manage to proliferate and develop into established nooplasms in an
otherwise hostile environment.
The finding that in the thymectomized group of mice the tumours arising in
males were more antigenic than those arising in females is interesting, but since it
was only in this group of mice that sufficient numbers were available for this
analysis it is not possible to draw any conclusions about its significance. Thy-
mectomy may have more severe effects in males than in females but, on the other
hand, tumours arising in males may normally be more antigenic than those in
females.
SUMMARY
Thymectomized C57B1 mice were injected subcutaneously with 0-25 mg. of
MC in olive oil. Intact mice ofthe same strain were injected with either 0*25 mg.
or 1 00 mg. of MC. The final incidence of sarcomas at the injection site was
significantly higher in intact mice given 1 00 mg. of MC than in the other mice.
Thymectomy, and the four-fold increase in the dose of MC administered, signifi-
cantly shortened the latent period of tumour induction, but the growth rate of
the tumours, once they had become established, was unaffected by the treatment
of the host. Tumours with the shortest latent period were the most highly
antigenic and those which appeared later showed progressively less and less
antigenicity. The tumours which appeared in the thymectomizedmice, and in the
mice which received a high dose of carcinogen, were more antigenic than those
appearing in intact mice given a low dose. The significance of these findings is
discussed.
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